Amarantus Bioscience Holdings Inc (AMBS)

[newflow]

United States Patent 9,547,012
Goldknopf January 17, 2017

Diagnosis of parkinson's disease

Abstract

A method of diagnosing Parkinson's disease uses the abnormal concentrations of a group of 21 blood serum protein biomarkers. The concentration of the 21 protein biomarkers is assessed in a patient's serum by quantitative two-dimensional polyacrylamide gel electrophoresis.
Inventors: Goldknopf; Ira Leonard (The Woodlands, TX)
Applicant:
Name City State Country Type

Goldknopf; Ira Leonard
The Woodlands
TX
US
Assignee: Amarantus Bioscience Holdings, Inc. (San Francisco, CA)
Family ID: 1000002350820
Appl. No.: 12/802,630
Filed: June 10, 2010

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=9,547,012.PN.&OS=PN/9,547,012&RS=PN/9,547,012